Pleural diseases and COVID-19: ubi fumus, ibi ignis

José M. Porcel

Source: Eur Respir J, 56 (5) 2003308; 10.1183/13993003.03308-2020
Journal Issue: November
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
José M. Porcel. Pleural diseases and COVID-19: ubi fumus, ibi ignis. Eur Respir J, 56 (5) 2003308; 10.1183/13993003.03308-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophilic pleural effusions – Is everything clear?
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012


Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


PG5 Pleural disease management
Source: Milan 2017 - Educational material
Year: 2017

Diagnostic yield of the new pleural biopsy needle ((Esmat’s needle)) in exudative pleural effusion
Source: International Congress 2016 – Pleural diseases
Year: 2016


Pleural disease
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Bronchoalvolar Lavage (BAL) in diffuse lung disease: Pros & Cons
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


Eosinophilic pleural effusions (EPES)
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009


Pleural endometriosis: Leading to hemothorax (A rare case)
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010


Malignant pleural effusion related empyema — etiology, pathogen, and management
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Induced sputum (IS) MMP- 9 and TIMP- 1 in granulomatous diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Fibrosing interstitial lung diseases: knowns and unknowns
Source: Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018
Year: 2019



Diagnostic values of inflammation biomarkers in pleural effusions (PE)
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015

Molecular assay for tuberculous pleural effusion
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Tuberculous pleural effusion
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Pleural infections: Place for thoracoscopy
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014

Pleural infections: Place for thoracoscopy
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014

Analysis of amylase rich pleural effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Infectious pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204
Year: 2002